Opportunities and challenges of Digital Transformation in the highly regulated pharmaceutical industry. Is the digital path even possible here?
Summary: In the pharmaceutical industry, safety and risk minimization are essential to ensure consistent product quality and meet validation requirements. Any changes—for example to manufacturing processes or formulations—must go through a detailed change control process. What this involves, the regulatory requirements that apply, and how your company can successfully handle them—you’ll find out in our article.
It’s not just important – it’s mandatory: the highly regulated pharmaceutical industry relies on strict change control. Whenever changes occur in a pharmaceutical company, this process governs and monitors them. But why are adjustments in this industry so tightly regulated? Careful control in a regulated environment ensures that medicines are produced and released to the market safely, effectively, in high quality, and always with the exact same composition.
Change control affects many areas of a company, including:
Alongside change control, pharmaceutical companies also rely on risk management and quality control. While each discipline serves a distinct purpose, they are closely interconnected.
Here’s what sets them apart:
Change control focuses on managing and monitoring changes across all aspects – from drug development to market launch. Every process is included.
Risk management, on the other hand, identifies, evaluates, monitors, and controls the safety, efficacy, and quality of medicines. The goal is to develop strategies that minimize risks and, ideally, prevent unwanted incidents altogether.
Quality control ensures that strict quality standards for pharmaceuticals are met by applying tests and proven techniques.
To reliably meet the stringent requirements of the pharmaceutical industry, these three areas work hand in hand. Together, they form the foundation that ensures patients receive safe and effective medicines.
Theory is all well and good, but what do changes actually look like in practice? While every project is different, these four types of adjustments are particularly common in pharmaceutical companies:
When manufacturing methods are modified, this impacts how medicines are produced. Such changes can also affect the equipment, technologies, and production techniques required.
Adjustments to ingredients often lead to changes in a drug’s formulation. This requires great care, as even minor modifications can influence the product’s efficacy, safety, or stability.
In the pharmaceutical industry, what’s on the outside matters too. Alterations to packaging or labeling can affect how a drug is identified and used. Preventing confusion or incorrect use is critical.
When authorities update the rules for approval, production, or marketing, pharmaceutical companies must ensure the new requirements are fully and efficiently implemented.
The entire pharmaceutical industry is governed by numerous legal and regulatory frameworks, all of which have a direct impact on change control. Compliance is critical for pharmaceutical companies—only then can the safety, efficacy, and quality of medicines be guaranteed, while ensuring full regulatory adherence. There are many such frameworks, and companies must comply with all of them. Some key examples include:
Approval rules and procedures differ from country to country. Whenever a manufacturing change is introduced, it must be fully documented.
GMP regulations define the standards that must be met during pharmaceutical production. Any change to the manufacturing process must be documented, assessed, and approved in line with GMP guidelines. A key element of the GMP framework is the ICH Q10 guideline, which specifically addresses pharmaceutical quality systems.
Quality management standards—most notably ISO 9001—set strict requirements for pharmaceutical quality management systems. This also includes the processes governing change control.
Regulatory authorities such as the FDA define the rules and requirements for changes to approved medicines. The European counterpart to the FDA is the European Medicines Agency (EMA).
GDP guidelines set the standards for how pharmaceutical processes and changes must be documented. They ensure that all adjustments are recorded properly and remain traceable at all times.
Meeting regulatory requirements, managing complex production processes, and ensuring seamless documentation of every change pose major challenges for pharmaceutical companies. The work is demanding and highly sensitive—where even the smallest error can have serious consequences. Yet with the right strategies and solutions, even the most complex tasks can be mastered with confidence.
To ensure change control is carried out correctly and reliably, the pharmaceutical industry commonly applies the following methods:
These procedures define the criteria that must be followed when evaluating, approving, implementing, and monitoring specific changes.
Particularly critical changes—for example, to manufacturing processes or formulations—require validation measures. These ensure that modifications are implemented properly and that the quality of the final product remains consistent and reproducible.
Clear communication is essential to ensure that everyone involved—both internally and externally—is informed about changes and their documentation. Training sessions prepare employees for upcoming adjustments and provide them with the knowledge they need to handle new processes confidently.
Another key factor in successful change control is meticulous documentation. It allows individual steps to be traced whenever necessary and ensures full transparency. Typical documentation management includes storing and recording:
Change control is not a one-time task but an ongoing process. Companies benefit from regularly reviewing and questioning affected workflows to drive continuous improvement and establish reliable best practices.
In addition to methods and strategies, the right tools help companies manage change control efficiently. They automate processes, boost efficiency, and ensure that every change remains traceable.
Specialized solutions designed for digital change control support pharmaceutical companies in managing changes efficiently. They capture, track, and manage change requests—often through workflows, notifications, and integrated document management.
A document management system also simplifies change control. It reliably manages and organizes all documentation, records, and guidelines in one central location. Digital access makes retrieving documents quick and straightforward at any time.
Dedicated tools for risk management—an important complement to change control—provide functions for risk analysis, assessment, and tracking of changes.
Collaboration platforms and project management solutions help companies plan and implement changes effectively. They streamline communication and ensure that all stakeholders work with the same data set—an essential foundation for efficient change control processes.
ERP solutions can simplify and connect all business processes, including change control. Workflow functions, integrated process management, batch traceability, and industry-specific features for formulation management, quality control, and more provide both security and efficiency. With Yaveon 365, our industry ERP designed specifically for the pharmaceutical sector, you benefit from exactly that—enhanced by the dedicated Quality Assurance App and many other essential functions.
For pharmaceutical companies, efficient change control is a core part of everyday operations. Meeting all requirements, however, can be a real challenge. The right mechanisms and digital tools help ensure that changes are documented not only completely but also accurately and seamlessly. To combine efficiency with compliance, an ERP system is the smart choice—it streamlines change control processes while automating many other workflows that would otherwise be time-consuming and error-prone.
Want to bring more security to your change control?
Discover our industry ERP, Yaveon 365, and launch reliable, compliant change processes.
Opportunities and challenges of Digital Transformation in the highly regulated pharmaceutical industry. Is the digital path even possible here?
GAMP 5 is the guideline for ensuring the quality and compliance of automated systems in the pharmaceutical industry.
Read how hameln pharma connects an external warehouse largely with a standard interface and saves time through automated processes.